Detail

Study ID: BTG TheraSphere HUD

Title:

A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma

Location:
Bismarck Region
Principal Investigator:
Brent Herbel, MD
Disease:
HEP (Liver Tumors)
Stage:
IDE
Status:
Active - Open to Accrual